SCHEMBL2503945

SCHEMBL2503945

CCCCOc1cc(COc2cccc([C@H](C)C(C)C(=O)O)c2)ccc1-c1cccc(OC)c1

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 16/20 0.53
PPARD Q03181 2/20 0.44
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2501352 1.00 FFAR1 (0.53) FFAR1PPARDPPARA
SCHEMBL2499805 0.94 FFAR1 (0.46) FFAR1
SCHEMBL2503693 0.94 FFAR1 (0.46) FFAR1
SCHEMBL2497801 0.89 FFAR1 (0.57) FFAR1
SCHEMBL2496841 0.89 FFAR1 (0.57) FFAR1
SCHEMBL2503210 0.88 FFAR1 (0.59) FFAR1
SCHEMBL2500923 0.88 FFAR1 (0.59) FFAR1
SCHEMBL2501348 0.86 FFAR1 (0.53) FFAR1
SCHEMBL2503943 0.86 FFAR1 (0.53) FFAR1
SCHEMBL2500878 0.85 FFAR1 (0.57) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030354-B2 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes AMGEN INC. (US) 2011-10-04 US disclosed